| Title | Frontiers in Clinical Drug Research - Anti Allergy Agents |
| Abbreviation | Front. Clin. Drug Res. - Anti Allergy Agents |
| Publication Type | Book series |
| Subject Area, Categories, Scope | Drug Discovery (Q4); Immunology and Allergy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4) |
| h-index | 1 |
| Overall Rank/Ranking | 25947 |
| SCImago Journal Rank (SJR) | 0.133 |
| Impact Score | 0.00 |
| Publisher | Bentham Science Publishers |
| Country | Netherlands |
| ISSN | 22146938, 24523194 |
| Best Quartile | Q4 |
| Coverage History | 2019-2020, 2022 |
Frontiers in Clinical Drug Research - Anti Allergy Agents is a book series covering the technologies/fields/categories related to Drug Discovery (Q4); Immunology and Allergy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4). It is published by Bentham Science Publishers. The overall rank of Frontiers in Clinical Drug Research - Anti Allergy Agents is 25947. According to SCImago Journal Rank (SJR), this book series is ranked 0.133. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This book series has an h-index of 1. The best quartile for this book series is Q4.
The ISSN of Frontiers in Clinical Drug Research - Anti Allergy Agents book series is 22146938, 24523194. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Frontiers in Clinical Drug Research - Anti Allergy Agents is cited by a total of 0 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Frontiers in Clinical Drug Research - Anti Allergy Agents is 0.00, which is computed in 2025 as per its definition. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.00 |
| 2023 | 0.00 |
| 2022 | 0.00 |
| 2021 | 0.15 |
| 2020 | 0.00 |
| 2019 | 0.00 |
Frontiers in Clinical Drug Research - Anti Allergy Agents has an h-index of 1. It means 1 articles of this book series have more than 1 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Frontiers in Clinical Drug Research - Anti Allergy Agents is 22146938, 24523194. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Frontiers in Clinical Drug Research - Anti Allergy Agents is 25947. According to SCImago Journal Rank (SJR), this book series is ranked 0.133. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.133 |
| 2023 | 0.111 |
| 2022 | 0.105 |
| 2021 | 0.109 |
| 2020 | 0.106 |
| 2019 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 25947 |
| 2023 | 26494 |
| 2022 | 25927 |
| 2021 | 24515 |
| 2020 | 29394 |
| 2019 | 30968 |
Frontiers in Clinical Drug Research - Anti Allergy Agents is published by Bentham Science Publishers. It's publishing house is located in Netherlands. Coverage history of this book series is as following: 2019-2020, 2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Frontiers in Clinical Drug Research - Anti Allergy Agents is Front. Clin. Drug Res. - Anti Allergy Agents. This abbreviation ('Front. Clin. Drug Res. - Anti Allergy Agents') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Drug Discovery (Q4); Immunology and Allergy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4), then please visit the official website of this book series.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Frontiers in Clinical Drug Research - Anti Allergy Agents latest impact IF is 0.00. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this book series are 0.15 (2021) and 0.00 (2024), respectively, in the last 6 years. Moreover, its average IS is 0.03 in the previous 6 years.
The Frontiers in Clinical Drug Research - Anti Allergy Agents has an SJR (SCImago Journal Rank) of 0.133, according to the latest data. It is computed in the year 2025. In the past 6 years, this book series has recorded a range of SJR, with the highest being 0.133 in 2024 and the lowest being in 2019. Furthermore, the average SJR of the Frontiers in Clinical Drug Research - Anti Allergy Agents over the previous 6-year period stands at 0.03.
The latest h-index of the Frontiers in Clinical Drug Research - Anti Allergy Agents is 1.
The Frontiers in Clinical Drug Research - Anti Allergy Agents is published by the Bentham Science Publishers, with its country of publication being the Netherlands.
The Frontiers in Clinical Drug Research - Anti Allergy Agents is currently ranked 25947 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 6 years, this book series has experienced varying rankings, reaching its highest position of 24515 in 2021 and its lowest position of 30968 in 2019.
The standard ISO4 abbreviation for the Frontiers in Clinical Drug Research - Anti Allergy Agents is Front. Clin. Drug Res. - Anti Allergy Agents.
Frontiers in Clinical Drug Research - Anti Allergy Agents is classified as a book series that the Bentham Science Publishers publishes.
The Frontiers in Clinical Drug Research - Anti Allergy Agents encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this book series.
The Frontiers in Clinical Drug Research - Anti Allergy Agents is assigned the following International Standard Serial Numbers (ISSN): 22146938, 24523194.
The best quartile for the Frontiers in Clinical Drug Research - Anti Allergy Agents is Q4 (2024).
The Frontiers in Clinical Drug Research - Anti Allergy Agents coverage history can be summarized as follows: 2019-2020, 2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Field Archaeology | journal | 7683 | Maney Publishing | 48 | 1.85 |
| Entrepreneurship Theory and Practice | journal | 168 | SAGE Publications Ltd | 212 | 13.35 |
| Archives of Phytopathology and Plant Protection | journal | 16692 | Taylor and Francis Ltd. | 35 | 1.42 |
| Journal, Indian Academy of Clinical Medicine | journal | 28559 | Indian Academy of Clinical Medicine | 16 | 0.10 |
| Howard Journal of Communications | journal | 14582 | Taylor and Francis Ltd. | 42 | 1.27 |
| Tekstilec | trade journal | 17340 | University of Ljubljana Press | 16 | 1.29 |
| Proteomics - Clinical Applications | journal | 8540 | Wiley-VCH Verlag | 67 | 2.59 |
| Acta Periodica Technologica | journal | 22883 | University of Novi Sad, Faculty of Technology | 22 | 0.71 |
| SPE International Formation Damage Control Symposium Proceedings | conference and proceedings | 21934 | 16 | 0.00 | |
| Expert Review of Clinical Pharmacology | journal | 4295 | Taylor and Francis Ltd. | 67 | 3.02 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.00 |
| 2023 | 0.00 |
| 2022 | 0.00 |
| 2021 | 0.15 |
| 2020 | 0.00 |
| 2019 | 0.00 |
